Tomato Powder vs. Lycopene for Exercise Oxidative Stress

Whole tomato powder beat isolated lycopene—but one small trial cannot settle the argument

If you take lycopene to limit oxidative damage after hard training, the best direct comparison does not favor the capsule. In a randomized, double-blind crossover trial, trained male athletes took either whole tomato powder or isolated lycopene at the same 30 mg daily lycopene dose. After an exhaustive exercise test, the tomato-powder condition reduced the rise in two lipid-peroxidation markers relative to placebo. The isolated-lycopene condition did not differ significantly from placebo on either marker.

That finding comes from a 2021 trial by Gholami et al., and it makes a sensible case for choosing tomato-based food over a pure lycopene supplement if your goal is this specific biomarker response. It does not prove that tomato powder improves performance, recovery, health, or longevity. The study included only 11 men, lasted one week per treatment period, and did not measure blood lycopene levels.

What the tomato-versus-lycopene trial actually tested

Each of the 11 well-trained male athletes completed three one-week treatment periods in randomized, double-blind crossover fashion, separated by two-week washouts. They consumed 60 g per day of whole tomato powder, isolated lycopene at 30 mg per day, or placebo. Because every participant received every condition, the design reduced the noise caused by differences between athletes.

The key comparison was unusually useful: the tomato powder and the capsule supplied the same stated lycopene dose. The tomato powder also contained 22.32 mg phytoene, 9.84 mg phytofluene, 5.38 mg beta-carotene, 76.44 mg vitamin C, and 3.62 mg vitamin E. After a standardized exhaustive exercise protocol, researchers measured malondialdehyde (MDA) and 8-isoprostane before and after exercise. Both are markers used to estimate lipid peroxidation, the oxidative damage of membrane fats.

Tomato powder significantly attenuated the post-exercise increases in MDA and 8-isoprostane versus placebo. It also increased post-exercise total antioxidant capacity. Isolated lycopene did not significantly differ from placebo for MDA, 8-isoprostane, or total antioxidant capacity. The publication reports statistical significance for these comparisons but does not provide a decision-ready between-condition effect estimate and confidence interval in the evidence summarized here.

The result is interesting because it tests a practical question, not just a laboratory theory: does 30 mg of lycopene work the same when it comes from a whole-food powder as when it comes from an isolate? In this trial, it did not.

The food matrix is plausible, but it is not yet proven as the cause

Tomatoes package lycopene with other carotenoids and vitamins that operate in different chemical settings. Vitamin C acts primarily in aqueous environments, vitamin E is membrane-associated, and carotenoids are fat-soluble. Those compounds could contribute separate antioxidant effects or help recycle one another. That is a plausible explanation for the tomato-powder result.

But plausibility is not proof. The study did not measure which component produced the effect, whether the components interacted, or whether participants absorbed equal amounts of lycopene in both conditions. "Food synergy" is often used as if it closes the case. Here it is a reasonable hypothesis with one direct trial behind it.

Other randomized food studies point in the same direction without replicating this exact comparison. In a 2025 placebo-controlled trial of jaboticaba juice, 24 trained participants consumed 250 mL daily for seven days; the juice contained about 1,300 mg total polyphenols. Compared with placebo, it improved plasma reduced glutathione and accelerated recovery after eccentric elbow-flexor exercise. That study examined a different fruit, intervention, and recovery model, so it cannot verify the tomato result. It does show that a complex plant-food preparation can change exercise-related biological outcomes in humans.

Likewise, a 2025 double-blind trial of flavonoid-enriched orange juice found improved antioxidant capacity and lipid-profile measures in obese adults following a low-calorie diet over six weeks. The population and question differ sharply from trained athletes facing an exhaustive exercise bout. It supports the broader possibility that plant-food formulations can have measurable effects, not a claim that every food matrix beats every isolated nutrient.

Why the capsule result may have failed

Three explanations remain on the table. First, the crystalline lycopene product may have delivered less absorbable lycopene than the tomato powder. Lycopene absorption depends on formulation, and oily or heat-processed tomato preparations can improve bioavailability. Because the investigators did not measure plasma lycopene, the study cannot distinguish poor delivery of the capsule from weaker biological activity of absorbed lycopene.

Second, the trial may have missed a modest capsule effect. Eleven participants is a very small sample for variable exercise biomarkers, and the authors reported no a priori power calculation. A crossover design helps, but it cannot manufacture precision from thin air.

Third, one week may not have been long enough for isolated lycopene to reach a useful tissue concentration. The trial included a two-week washout, but it did not demonstrate tissue loading during either active condition.

These concerns matter because MDA and 8-isoprostane are surrogate endpoints, not athlete-centered outcomes. MDA measured by the TBARS method can reflect aldehydes beyond lipid-peroxidation products. An 8-isoprostane ELISA can also cross-react with similar molecules unless a mass-spectrometry method confirms the result. Neither limitation makes the findings worthless; both make a small positive trial easier to overread.

Oxidative-stress markers are real signals, not a scorecard for training quality

Hard exercise can acutely raise oxidative-stress markers. A 2022 crossover study in recreationally trained women documented exercise-related differences in blood MDA and showed how much biological variability these measures carry. A randomized caffeine trial in 13 recreational runners also measured oxidative-stress markers around a 3-km run, confirming that this sort of exercise challenge can generate detectable signals.

Still, reducing a biomarker spike is not automatically desirable or useful. Training adaptations involve redox signaling, and this tomato study did not measure strength, time to exhaustion, race performance, soreness, injury, or long-term recovery. It measured acute biochemical responses after one exhaustive bout.

The broader supplement literature also resists simple rules. A 2025 meta-analysis of CoQ10 trials in athletes pooled 17 trials with 440 participants and reported lower MDA, with a mean difference of -0.61 μmol/L (95% CI, -1.18 to -0.03; p=0.04), along with lower LDH and creatine kinase. That finding shows that an isolated compound can affect oxidative-stress and muscle-damage markers under some circumstances. Its heterogeneous results do not rescue the lycopene capsule in the tomato trial, but they do weaken any blanket claim that isolates inherently fail.

Conversely, whole-food interventions do not reliably lower oxidative-stress biomarkers either. In a randomized crossover trial of beetroot juice, 16 adults aged 65 to 79 improved muscle speed and power after acute and two-week nitrate-rich beetroot juice supplementation, but oxidative-stress markers did not improve. Food form is not a magic pass.

What to do with this result

For athletes who want to test a tomato-based approach, the directly studied regimen was 60 g per day of whole tomato powder, supplying 30 mg lycopene, for one week. Tomato paste and cooked tomato products may offer a practical food-first alternative, but they were not tested in this head-to-head trial, so no equivalent dose can be claimed.

A 30 mg crystalline lycopene capsule did not significantly improve the trial's two lipid-peroxidation markers. That is useful negative evidence, especially because the comparator dose matched the tomato powder's lycopene content. It is not proof that lycopene itself cannot work in a better-absorbed formulation, at a longer duration, or in another population.

The sensible conclusion is modest: whole tomato powder is the better-supported bet than isolated lycopene for reducing these acute exercise biomarkers, because it won the only direct comparison. The evidence rests on 11 male athletes and surrogate outcomes, so it should guide curiosity—not a grand supplement doctrine.